光正眼科医院集团股份有限公司 近日，公司完成了关于变更注册资本、变更企业类型的工商变更登记，并取 得了换发的《营业执照》。最新营业执照基本信息如下： 5、注册地址：新疆乌鲁木齐经济技术开发区融合北路 266 号 6、企业类型：其他股份有限公司（上市） 7、成立日期：2001 年 12 月 10 日 8、经营范围：一般项目：各类眼科疾病诊疗，医学验光配镜，眼科医院的 投资,眼科医院经营管理服务,眼科医疗技术的研究;天然气的销售、运输；建筑钢 结构；对外投资；房屋租赁；物业服务；咨询服务。（除依法须经批准的项目外， 凭营业执照依法自主开展经营活动） 证券代码：002524 证券简称：光正眼科 公告编号：2025-075 光正眼科医院集团股份有限公司 关于公司完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 光正眼科医院集团股份有限公司（以下简称"公司"）于 2025 年 9 月 4 日召 开公司 2025 年度第二次临时股东大会，审议通过了《关于修订<公司章程>的议 案》及《关于工商变更企业类型并修订＜公司章程＞的议案》，具体内 ...

Core Insights - The collaboration between Tongji University Affiliated Tongji Hospital and Guangzheng Ophthalmology has led to the development of innovative glaucoma drainage valves and anterior chamber puncture devices, winning multiple awards at national competitions [1][2] Group 1: Awards and Recognition - The glaucoma treatment patent won first prize and third prize at the 2025 China Medical Device Innovation and Entrepreneurship Competition, and second prize at the 2025 Yangtze River Delta Industrial Innovation Patent Operation Competition [1] - The awarded patents are now entering subsequent research trials and clinical application phases, supported by collaborations and financing from several well-known medical technology companies [2] Group 2: Collaborative Innovation - Guangzheng Ophthalmology has established three major innovation platforms in collaboration with top institutions, focusing on AI ophthalmic diagnostic systems and minimally invasive treatment device development [3] - The recent patent breakthrough in glaucoma treatment reflects the success of Guangzheng Ophthalmology's innovation research system, emphasizing its commitment to driving advancements in ophthalmic medical technology [3] Group 3: Future Directions - Guangzheng Ophthalmology plans to leverage the recent awards to deepen its focus on the "AI + healthcare" sector, enhancing partnerships with academic and research institutions [3] - The company aims to increase investment in cutting-edge fields such as AI diagnosis and gene therapy, integrating innovative results into its medical service network for broader patient benefit [3]

Core Viewpoint - Guangzheng Eye Hospital (002524) reported that as of November 20, 2025, the total number of shareholders is 36,396 [1] Summary by Category - **Company Information** - Guangzheng Eye Hospital has a total of 36,396 shareholders as of the specified date [1]

光正眼科医院集团股份有限公司 光正眼科医院集团股份有限公司 关于 2023 年限制性股票激励计划部分限制性股票回购注销 完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：002524 证券简称：光正眼科 公告编号：2025-074 特别提示： 1.光正眼科医院集团股份有限公司（以下简称"公司"）2023 年限制性股 票激励计划（以下简称"本激励计划"）本次回购注销的限制性股票数量为 3,135,500 股，占回购注销前公司总股本的 0.60%。本次回购注销涉及首次授予 252 名激励对象，回购价格为 3.30 元/股，预留授予 3 名激励对象，回购价格为 1.62 元/股。本次回购注销完成后，公司股份总数由 518,467,074 股减少至 515,331,574 股。 2.截至本公告披露日，公司已在中国证券登记结算有限责任公司深圳分公司 办理完成上述限制性股票的回购注销手续。 一、限制性股票激励计划的具体情况 1.2023 年 8 月 23 日，公司第五届董事会第十九次会议审议通过了《关于公 司<2023 年限制性股票激励计划（草案）>及 ...

Market Overview - The medical services sector increased by 0.56% on November 25, with ST Zhongzhu leading the gains [1] - The Shanghai Composite Index closed at 3870.02, up 0.87%, while the Shenzhen Component Index closed at 12777.31, up 1.53% [1] Top Gainers in Medical Services - ST Zhongzhu (600568) closed at 2.57, up 4.90% with a trading volume of 53,900 shares and a turnover of 13.85 million yuan [1] - Chengda Pharmaceutical (301201) closed at 47.78, up 2.97% with a trading volume of 112,700 shares and a turnover of 540 million yuan [1] - Boji Pharmaceutical (300404) closed at 10.10, up 2.75% with a trading volume of 108,600 shares and a turnover of 10.9 million yuan [1] Top Losers in Medical Services - Jiuzhou Pharmaceutical (603456) closed at 18.75, down 0.85% with a trading volume of 181,100 shares and a turnover of 343 million yuan [2] - Tongce Medical (600763) closed at 41.95, down 0.66% with a trading volume of 49,600 shares and a turnover of 210 million yuan [2] - Yingkang Life (300143) closed at 10.12, down 0.49% with a trading volume of 44,700 shares and a turnover of 4.56 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 113 million yuan from institutional investors, while retail investors saw a net inflow of 30.37 million yuan [2][3] - Major stocks like WuXi AppTec (603259) had a net inflow of 67.13 million yuan from institutional investors, while Sunshine Nuohua (688621) saw a net outflow of 2.29 million yuan from retail investors [3] Summary of Individual Stock Performance - Sunshine Nuohua (688621) had a net inflow of 38.24 million yuan from institutional investors, but a net outflow of 3.59 million yuan from retail investors [3] - Chengda Pharmaceutical (301201) also saw a significant net inflow of 36.45 million yuan from institutional investors, with a net outflow of 13.58 million yuan from retail investors [3] - New Mileage (002219) had a net inflow of 14.15 million yuan from institutional investors, while retail investors experienced a net outflow of 6.70 million yuan [3]

Market Overview - The medical services sector experienced a decline of 2.71% on November 21, with Baihua Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3834.89, down 2.45%, while the Shenzhen Component Index closed at 12538.07, down 3.41% [1] Stock Performance - Notable gainers included Yangguang Nuohua, which rose by 4.47% to a closing price of 61.21, with a trading volume of 86,300 shares and a transaction value of 530 million [1] - Baihua Pharmaceutical saw a significant decline of 9.67%, closing at 9.06, with a trading volume of 292,400 shares and a transaction value of 275 million [2] - Other notable decliners included Chengda Pharmaceutical (-9.58%), Berry Genomics (-8.67%), and Guangzheng Eye Hospital (-7.26%) [2] Capital Flow - The medical services sector experienced a net outflow of 1.325 billion in institutional funds, while retail investors saw a net inflow of 1.332 billion [2] - The table of capital flow indicates that major stocks like Yangguang Nuohua had a net inflow of 10.986 million from institutional investors, while retail investors had a net inflow of 1.374 million [3]

光正眼科医院集团股份有限公司 证券代码：002524 证券简称：光正眼科 公告编号：2025-073 光正眼科医院集团股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.会议召开的日期、时间： 1、本次股东大会未出现否决议案的情况； 现场会议时间为：2025 年 11 月 14 日（星期五）下午 14:30； 2、本次股东大会不涉及变更以往股东大会已通过的决议； 网络投票时间为：2025 年 11 月 14 日。其中：通过深圳证券交易所交易系 统进行网络投票的具体时间为 2025 年 11 月 14 日 9:15—9:25,9:30—11:30 和 13:00—15:00；通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 11 月 14 日 9:15—15:00 期间的任意时间。 一、 会议召开情况 3.会议的召开方式：本次股东大会采取现场投票与网络投票相结合的方式； 4.会议召集人：公司第六届董事会； 5.会议主持人：董事长周永麟； 6.会议的召集、召开符合《中华人民共和国公司法 ...

T&P 新疆天阳律师事务所 光正眼科 2025 年度第三次临时股东会 新疆天阳律师事务所 关于光正眼科医院集团股份有限公司 2025 年度第三次临时股东会 法律意见书 天阳证股字[2025]第 43 号 新疆天阳律师事务所 二○二五年十一月 地址：新疆乌鲁木齐市水磨沟区红光山路 888 号绿城广场写字楼 2A 座 7 层 1 T&P 新疆天阳律师事务所 光正眼科 2025 年度第三次临时股东会 新疆天阳律师事务所 关于光正眼科医院集团股份有限公司 2025 年度第三次临时股东会 法律意见书 天阳证股字[2025]第 43 号 致：光正眼科医院集团股份有限公司 新疆天阳律师事务所（下称"本所"）接受光正眼科医院集团股份有限公司 （下称"公司"）的委托，委派本所康晨律师、尹杰律师出席公司 2025 年度第 三次临时股东会，根据《中华人民共和国公司法》（下称"《公司法》"）、《中 华人民共和国证券法》（下称"《证券法》"）、《上市公司股东会规则》和《光 正眼科医院集团股份有限公司章程》（下称"《公司章程》"），按照律师行业 公认的业务标准、道德规范和勤勉尽责精神，对有关的文件和事实进行核查与验 证，并出具法律意见。 ...

Core Viewpoint - Guangzheng Eye Hospital announced that neither the company nor its subsidiaries have provided guarantees to any units or individuals outside the scope of the consolidated financial statements, and there are no overdue debts related to guarantees, litigation guarantees, or guarantees arising from judgments against the company [1] Summary by Categories - **Company Guarantees** - The company has not provided any guarantees to entities or individuals outside the consolidated financial statements [1] - **Debt and Litigation Status** - There are no overdue debts associated with guarantees, nor are there any guarantees related to litigation or judgments against the company [1]

Core Viewpoint - The company plans to apply for a comprehensive credit line of up to 650 million yuan from financial institutions by 2025, with a total guarantee amount of 497 million yuan, which represents 441.07% of the latest audited net assets attributable to the parent company [1] Group 1 - The company and its subsidiaries will provide a cumulative guarantee limit of no more than 650 million yuan, valid for 12 months [1] - The wholly-owned subsidiary, Guangzheng New Vision, has initiated a financing lease business of 10 million yuan, with the company providing joint liability guarantees [1] - New Vision Eye Hospital has applied for a credit limit of 20 million yuan, with the company and Guangzheng New Vision providing joint liability guarantees [1]